According to NCPA’s member priority survey for 2017, the top three issues of 2016 – DIR fees, reimbursements, and “any willing provider” provision – are still problematic for pharmacists in 2017. However, direct and indirect remuneration (DIR) fees were voted as the current most problematic issue for community pharmacists.
NCPA revealed that one-third of pharmacists reported DIR fees as their top advocacy priority, which is a 10% increase from 2016’s survey. Douglas Hoey, CEO of the National Community Pharmacists Association (NCPA) released an executive update that summarizes the survey’s findings and NCPA’s approach to solving these issues.
Community pharmacists are encouraged to be active in advocacy efforts, including contacting bill cosponsors and members of Congress. Hoey even encourages pharmacists to attend the Congressional Pharmacy Fly-In in Washington, D.C. to advocate for pharmacy.
For more information, read Hoey’s Executive Update here.
Read our exposé on DIR fees here.